SCHEMBL19957477

SCHEMBL19957477

Cc1cnc2ccc(Br)cc2c1S

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.45
HTT P42858 5/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 1/20 0.41
CHEK1 O14757 1/20 0.41
PIM1 P11309 1/20 0.41
AKT1 P31749 1/20 0.41
FLT3 P36888 1/20 0.41
PIM3 Q86V86 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
MAPK1 P28482 2/20 0.39
CASP3 P42574 2/20 0.39
SLC22A12 Q96S37 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899569 0.79 TNF (0.51) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL14899564 0.79 TNF (0.45) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL19957465 0.79 PARP1 (0.41) HTTLMNACCNCCDK8CASP3
SCHEMBL741042 0.72 SLC22A12 (0.53) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL1557613 0.71 TNF (0.42) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL21190488 0.71 TNF (0.55) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL4745808 0.71 EGFR (0.43) TNFHTTLMNASMN1; SMN2TSHR
SCHEMBL8021772 0.68 HTT (0.57) HTTLMNASMN1; SMN2ALDH1A1CCNC
SCHEMBL16247955 0.68 SLC22A12 (0.49) HTTLMNASMN1; SMN2CHEK1PIM1
SCHEMBL28546764 0.68 HTT (0.53) HTTLMNASMN1; SMN2CHEK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998296-B1 CYCLOALKYL ACID DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL APPLICATION THEREOF Shanghai hengrui pharmaceutical co ltd (CN) 2018-03-14 EP disclosed